PMID: 9192667Jun 24, 1997Paper

Effect of tissue factor deficiency on mouse and tumor development

Proceedings of the National Academy of Sciences of the United States of America
J R ToomeyGeorge Broze

Abstract

Previous reports suggest that tissue factor (TF) may play an essential role in embryonic vascular development and tumor angiogenesis. To further examine this relationship, the morphology of fully developed TF-deficient embryos and the growth of TF-deficient teratomas and teratocarcinomas were analyzed. In a 129/Sv genetic background, TF null embryos do not survive beyond mid-gestation. In contrast, 14% of 129/Sv x C57BL/6 TF-deficient embryos escape this early mortality and survive to birth. On gross and microscopic inspection, these late gestation, TF-deficient embryos appear normal. The growth and vascularity of TF(+/+), TF(+/-), and TF(-/-) teratomas and teratocarcinomas are indistinguishable. Thus, tumor-derived TF is not required for tumor growth and angiogenesis and the combined data do not support an essential role for TF in embryonic vascular development.

References

Nov 1, 1992·Cancer Metastasis Reviews·L V Rao
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B M MuellerW Ruf
Jan 1, 1991·Annual Review of Biochemistry·H R Herschman
Jun 1, 1989·Molecular and Cellular Biology·S A GregoryT S Edgington
Mar 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L F Lau, D Nathans
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P P NawrothD M Stern
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M P BevilacquaM A Gimbrone
Jun 1, 1983·The Journal of Clinical Investigation·M ColucciN Semeraro
Sep 1, 1994·The Journal of Clinical Investigation·Y ZhangP P Nawroth
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E BrombergA Garen
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·T H BuggeJ L Degen
Sep 5, 1996·Nature·P CarmelietD Collen

❮ Previous
Next ❯

Citations

Mar 9, 2004·Blood Cells, Molecules & Diseases·Saskia H H F SchoenmakersC Arnold Spek
Sep 21, 2000·Early Human Development·C S EdstromR D Christensen
May 23, 2001·Trends in Cardiovascular Medicine·M T Wiiger, H Prydz
Feb 28, 2004·Trends in Cardiovascular Medicine·M VikkulaB R Olsen
Jun 2, 1998·Kidney International·P Carmeliet, D Collen
Jul 23, 2008·Seminars in Thrombosis and Hemostasis·Rafal Pawlinski, Nigel Mackman
Aug 13, 2008·Current Opinion in Hematology·Janusz RakJoanne Yu
Oct 24, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·L Vijaya Mohan Rao, Usha R Pendurthi
Mar 21, 1998·The Journal of Clinical Investigation·G C ParryN Mackman
Jun 7, 2000·The Journal of Clinical Investigation·G C Parry, N Mackman
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·W Y SunS J Degen
Jun 15, 2012·Thrombosis Research·Jay L Degen, Joseph S Palumbo
May 15, 2010·Thrombosis Research·Delphine GarnierJanusz Rak
Mar 17, 2009·Best Practice & Research. Clinical Haematology·Janusz RakJoanne Yu
Nov 21, 2007·Thrombosis Research·Eric Camerer
Oct 7, 2008·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Janusz RakJoanne Yu
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·W Ruf
May 31, 2011·Journal of Experimental & Clinical Cancer Research : CR·Chengcheng XuXiangning Fu
Aug 21, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Yong-Jiang YuZuo-Yi Jiao
Jul 2, 2009·Organogenesis·Emanuele CozziErmanno Ancona
Apr 6, 2005·Journal of the American College of Cardiology·Björn SzotowskiUrsula Rauch
Mar 30, 1999·Experimental Cell Research·M MüllerT Luther
Feb 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Nathalie MagnusJanusz Rak
Jan 1, 2010·The American Journal of Pathology·Graciela KrikunCharles J Lockwood
May 26, 2006·British Medical Bulletin·Emanuele CozziErmanno Ancona
Jun 30, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Randal J WestrickDaniel T Eitzman
Sep 6, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Joanne YuJanusz Rak
Jul 25, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Chloe MilsomJanusz Rak
Jul 11, 2007·Journal of Cellular Physiology·Raphael RubinMarco Prisco
Jun 14, 2000·The Journal of Biological Chemistry·H H VersteegM P Peppelenbosch
Apr 26, 2002·The Journal of Biological Chemistry·Xiaolin WangHans Prydz
Feb 24, 2000·The Journal of Pathology·K T PreissnerS M Kanse
Jul 15, 2020·The Journal of Clinical Investigation·Sol SchulmanBruce Furie
Jul 20, 2001·Annals of the New York Academy of Sciences·J L DegenT T Suh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.